ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,722.26
      -0.19%
      US Tech 100
      19,517.20
      0.53%
      Dow Jones
      41,914.75
      -0.70%
      Brent Oil
      73.045
      -0.20%
      Bitcoin
      63,472.71
      0.54%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gilead Sciences Inc (GILD)

      7. Gilead Sciences Inc (GILD) News

      GILD

      Gilead Sciences (GILD)

      Gilead Sciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GILD
      DateTimeSourceHeadlineSymbolCompany
      09/13/20247:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      09/13/20245:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      09/12/20244:45PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GILDGilead Sciences Inc
      09/12/20244:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GILDGilead Sciences Inc
      09/12/20248:30AMBusiness WireGilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and Demonstrated Superiority to Daily Truvada® in Second Pivotal Phase 3 TrialNASDAQ:GILDGilead Sciences Inc
      09/11/20247:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      09/11/20247:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      09/11/20247:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      09/11/20247:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      09/11/20247:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      09/11/20247:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      09/10/20248:00AMBusiness WireGilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel TherapiesNASDAQ:GILDGilead Sciences Inc
      09/05/20248:00AMBusiness WireGilead to Present New Trodelvy® Data at the IASLC 2024 World Conference on Lung CancerNASDAQ:GILDGilead Sciences Inc
      08/29/20243:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      08/28/20244:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GILDGilead Sciences Inc
      08/21/20244:05PMBusiness WireGilead Sciences to Present at Upcoming Investor ConferencesNASDAQ:GILDGilead Sciences Inc
      08/14/20242:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      08/14/20241:59PMBusiness WireGilead’s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDANASDAQ:GILDGilead Sciences Inc
      08/13/20244:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GILDGilead Sciences Inc
      08/12/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      08/08/20245:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GILDGilead Sciences Inc
      08/08/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GILDGilead Sciences Inc
      08/08/20244:02PMBusiness WireGilead Sciences Announces Second Quarter 2024 Financial ResultsNASDAQ:GILDGilead Sciences Inc
      08/08/20245:55AMIH Market NewsU.S. Index Futures Drop, Signaling Ongoing Market Volatility; Oil Prices StallNASDAQ:GILDGilead Sciences Inc
      07/26/20245:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GILDGilead Sciences Inc
      07/25/20244:05PMBusiness WireGilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024NASDAQ:GILDGilead Sciences Inc
      07/25/20249:15AMBusiness WireGilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and PipelineNASDAQ:GILDGilead Sciences Inc
      07/24/20244:30AMBusiness WireFull Efficacy and Safety Results for Gilead Investigational Twice-Yearly Lenacapavir for HIV Prevention Presented at AIDS 2024NASDAQ:GILDGilead Sciences Inc
      07/22/20244:00AMBusiness WireGilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership to Help Address the Growing HIV Crisis in Eastern Europe and Central AsiaNASDAQ:GILDGilead Sciences Inc
      07/17/20249:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GILDGilead Sciences Inc
       Showing the most relevant articles for your search:NASDAQ:GILD